Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4E family member 2 pseudogene 2 (EIF4E2P2) is a nonfunctional pseudogene in the human genome. It shows sequence homology to the functional EIF4E2 gene but contains mutations or defects that render it incapable of encoding a protein. Pseudogenes like EIF4E2P2 can arise through duplication or retrotransposition events but generally lack regulatory sequences or suffer disabling mutations. While pseudogenes occasionally give rise to functional RNAs or acquire regulatory roles, there is no evidence that EIF4E2P2 produces any transcriptionally active or functional products[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4E family member 2 pseudogene 2 (EIF4E2P2).